Efficacy And Safety of Three Doses of Tipranavir Boosted with Ritonavir in Treatment-Experienced HIV Type 1-Infected Patients-Reference-Cited by-同舟云学术

Efficacy And Safety of Three Doses of Tipranavir Boosted with Ritonavir in Treatment-Experienced HIV Type 1-Infected Patients

Published:2007-02 Issue:2 Volume:23 Page:216-223
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Gathe Joseph C.¹,Pierone Gerald²,Piliero Peter³⁴,Arasteh Keikawus⁵,Rubio Rafael⁶,Lalonde Richard G.⁷,Cooper David⁸,Lazzarin Adriano⁹,Kohlbrenner Veronika M.¹⁰,Dohnanyi Catherine¹⁰,Sabo John¹⁰,Mayers Douglas¹⁰

Affiliation:

1. Therapeutic Concepts, Houston, Texas 77004.

2. Treasure Coast Infectious Disease Consultants, Vero Beach, Florida.

3. Albany Medical College, Albany, New York.

4. Present address: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.

5. Epimed GmbH c/o Vivantes Auguste-Viktoria-Hospital, Berlin, Germany.

6. Hospital 12 de Octubre Pabellon de Medicina Communitaria Unidad de VIH, Madrid, Spain.

7. Montreal Chest Institute, Montreal, Quebec, Canada.

8. University of New South Wales, Sydney, Australia.

9. San Raffaele Scientific Institute, Milan, Italy.

10. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2006.0178

Reference17 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. HIV therapy in 2003

3. Determinants of survival following HIV-1 seroconversion after the introduction of HAART

4. The prevalence of antiretroviral drug resistance in the United States

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Parameters of HIV‐1 Protease Inhibitors;ChemMedChem;2020-05-26

2. Risk of Spontaneous Intracranial Hemorrhage in HIV-infected Individuals: A Population-based Cohort Study;Journal of Stroke and Cerebrovascular Diseases;2013-10

3. Hepatotoxicity of Antiviral Agents;Drug-Induced Liver Disease;2013

4. Differences in implementation of HIV/AIDS clinical research in developed versus developing world: an evidence-based review on protease inhibitor use among women and minorities;International Journal of STD & AIDS;2012-12

5. Liver Toxicity of Antiretroviral Drugs;Seminars in Liver Disease;2012-05